JPM’s China JV head leaves for biopharma firm
A senior JP Morgan banker and head of its China securities joint venture has decided to leave his banking career for a job with a Hong Kong-listed Chinese drugmaker.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts